SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

04 Nov 2022 Evaluate
The sales surged to Rs. 720.03 millions, up 27.23% for the September 2022 quarter as against Rs. 565.94 millions during the corresponding quarter previous year.The Net Profit of the company registered a slight decline of -12.14% to Rs. 103.45  millions from Rs. 117.74 millions.The company reported a degrowth in operating Profit to 179.59 millions from 184.57 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 720.03 565.94 27.23 1225.31 1150.99 6.46 2193.51 2084.77 5.22
Other Income 21.77 13.22 64.67 34.11 23.54 44.90 46.57 16.48 182.58
PBIDT 179.59 184.57 -2.70 283.91 376.38 -24.57 652.26 736.41 -11.43
Interest 17.43 3.53 393.77 30.12 7.20 318.33 24.68 39.47 -37.47
PBDT 162.16 181.04 -10.43 253.79 369.18 -31.26 627.58 644.16 -2.57
Depreciation 23.37 23.22 0.65 47.30 46.20 2.38 95.02 96.33 -1.36
PBT 138.79 157.82 -12.06 206.49 322.98 -36.07 532.56 547.83 -2.79
TAX 35.34 40.08 -11.83 52.99 82.87 -36.06 137.39 148.82 -7.68
Deferred Tax 0.10 2.34 -95.73 -2.42 -4.69 -48.40 -5.14 -14.83 -65.34
PAT 103.45 117.74 -12.14 153.50 240.11 -36.07 395.17 399.01 -0.96
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 24.94 32.61 -23.52 23.17 32.70 -29.14 29.74 35.32 -15.82

Hester Biosciences Share Price

1492.80 20.80 (1.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×